Why the $300 generic EpiPen will just extend Mylan's profitability(perfectprice.io) |
Why the $300 generic EpiPen will just extend Mylan's profitability(perfectprice.io) |
I see analogues to some store-brand items that are in fact made by a big brand using its excess production capacity, or a family of brands that has similar-but-distinct products at different price points.
With pharmaceuticals, production capacity is hardly an issue. It will, ironically, cost Mylan more to make the "generic" new brand (pay for new branding, packaging, etc.) than it will to make and package the existing brand.